Market Cap
Pfizer Inc.
$149.84 Billion
USD as of Jan. 1, 2025
Company | Market Cap (USD) |
---|---|
![]() |
$689.42 B |
![]() |
$353.05 B |
![]() |
$301.60 B |
![]() |
$244.44 B |
![]() |
$219.35 B |
Company | Market Cap (USD) |
---|---|
![]() |
$689.42 B |
![]() |
$622.07 B |
![]() |
$487.54 B |
![]() |
$353.05 B |
![]() |
$301.60 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Pfizer Inc. is one of the world's largest pharmaceutical corporations, developing and producing diverse medicines and vaccines. Its leading products include Lipitor (to lower LDL blood cholesterol), Lyrica (for neuropathic pain and fibromyalgia), Diflucan (antifungal medication), Zithromax (antibiotic), Viagra (for erectile dysfunction), and Celebrex (anti-inflammatory drug).
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.